United States· US:87717-502_562d1b9a-09d9-92fc-e063-6394a90a1993
Docusate Sodium and Sennosides
A medicinal product containing docusate sodium; sennosides, registered in United States by Morepen Bio Inc.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- DOCUSATE SODIUM; SENNOSIDES
- Manufacturer
- Morepen Bio Inc
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- August 9, 2026
Packs & prices · 1
- ndc1187717-502-01
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Docusate sodium; sennosides in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/881ccb3b-111f-4e45-896e-11942f77652c GET /v1/drugs/881ccb3b-111f-4e45-896e-11942f77652c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "50; 8.6",
"substance": "DOCUSATE SODIUM; SENNOSIDES",
"productndc": "87717-502",
"dosage_form": "TABLET",
"dea_schedule": null,
"strength_unit": "mg/1; mg/1",
"application_number": "M007",
"marketing_category": "OTC MONOGRAPH DRUG"
}See everything about docusate sodium; sennosides.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.